Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1609–1632 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Pulmonary Embolism, Right Ventricular Dysfunction, Right Ventricular Failure
Interventions: Ultrasound-facilitated, catheter-directed lower-dose fibrinolysis, Tissue Plasminogen Activator; Device · Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Segmental Dysfunction of the Lumbar Spine, Back Pain, Leg Pain
Interventions: Chiropractic, Exercise, Cryotherapy, Spinalator; Other · Device
Lead sponsor: Leach Chiropractic Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Starkville, Mississippi

Conditions: Critical Illness
Interventions: Not listed
Lead sponsor: Children's Healthcare of Atlanta; Other
Eligibility: 5 Months and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Memory Disorders in Old Age
Interventions: High definition transcranial electrical current stimulation; Device
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years to 80 Years
Enrollment: 964 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coronary Artery Disease
Interventions: Febuxostat, Febuxostat placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Mild Cognitive Impairment, Alzheimer Disease, Alzheimer's Disease
Interventions: Time-restricted eating; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 60 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: Endothelial Dysfunction
Interventions: Atazanavir, Lopinavir/ritonavir, Placebo; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Children With Heart Transplants
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: Not listed
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Chemo-brain
Interventions: Transcranial magnetic stimulation (TMS); Device
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Cognitive Impairment, Voice Disorders, Voicebox Disorders, Cognitive Decline, Swallowing Disorder
Interventions: Speech Therapy, Swallowing Therapy, Upper Airway Therapy; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 60 Years to 110 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 4
States / cities: San Francisco, California • Atlanta, Georgia • New York, New York

Conditions: Cognitive Impairment
Interventions: beta-alanine, placebo; Dietary Supplement
Lead sponsor: University of Central Florida; Other
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Cognition Disorders
Interventions: Not listed
Lead sponsor: University of Southern California; Other
Eligibility: 65 Years to 85 Years
Enrollment: 538 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2023
U.S. locations: 40
States / cities: Birmingham, Alabama • Phoenix, Arizona • Sun City, Arizona + 32 more

Conditions: Congenital Heart Disease
Interventions: Blood draws; Other
Lead sponsor: Emory University; Other
Eligibility: Up to 1 Year
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Sleep Disorder, Circadian Dysregulation
Interventions: Trans-C for sleep and circadian function + Memory Support; Behavioral
Lead sponsor: University of California, Berkeley; Other
Eligibility: 55 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Alzheimer's Disease
Interventions: Riluzole, Placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 50 Years to 95 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 2
States / cities: New York, New York

Conditions: Allografts, Rejection; Transplant, Kidney, Transplant Rejection, Kidney Transplantation
Interventions: Belatacept, VIB4920, Thymoglobulin, Methylprednisolone; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 4
States / cities: Los Angeles, California • San Francisco, California • Durham, North Carolina + 1 more

Conditions: Alzheimer's Disease, Behavioral Variant Frontotemporal Dementia
Interventions: LMTM; Drug
Lead sponsor: TauRx Therapeutics Ltd; Industry
Eligibility: Not listed
Enrollment: 913 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 57
States / cities: Phoenix, Arizona • Fountain Valley, California • Laguna Hills, California + 48 more

Conditions: Physical Activity, Cancer of the Prostate, Cognitive Impairment, Quality of Life
Interventions: Supervised Physical Activity Plus Behavioral Counseling, Supervised Physical Activity Plus Exercise Counseling; Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years to 80 Years · Male only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Chronic Granulomatous Disease, Crohn'S-like IBD, Inflammatory Bowel Disease (IBD)
Interventions: Infliximab; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 10 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mood Disorder
Interventions: Lithium; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 7 Years to 85 Years
Enrollment: 2,350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Lymphoma Cancer, Breast Cancer, Cancer of the Breast, Non-Hodgkin Lymphoma, Hodgkin Lymphoma
Interventions: 68Ga-Galmydar, PET/MRI, 18F-FDG; Drug · Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 21 Years to 99 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Cognitive Impairment, Dementia, Mild, Cognitive Decline
Interventions: RACS app; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 60 Years and older
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Chronic Urogenital Pain
Interventions: Life-Stress Interview; Behavioral
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Sexual Dysfunction, Physiological
Interventions: VR101 Lubricating Intravaginal Ring, Sham Ring; Device
Lead sponsor: J3 Bioscience, Inc.; Industry
Eligibility: 21 Years and older · Female only
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 2
States / cities: Meridian, Idaho • West Jordan, Utah

Search by objective public record fields.

Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE

Clinical Correlates of Pressure Pain Thresholds in Back and Leg Pain

Neuroendocrine Dysfunction in Critically Ill Pediatric Patients

Improving Working Memory in Older Adults

The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable Angina

TREAD: Time Restricted Eating Intervention for Alzheimer's Disease

Effect of the HIV Protease Inhibitors Atazanavir and Lopinavir/Ritonavir on Cardiovascular Disease Risk Factors

Tissue Doppler Echo Imaging of Heart Function After Transplant

Treatment of Post-Chemo Cognitive Impairment w/Transcranial Magnetic Stimulation (Chemobrain TMS)

Correlation Between Montreal Cognitive Assessment and Voice Therapy Outcomes in the Aging Treatment- Seeking Population

Changes in Cognition During a 24-h Simulated Military Operation

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study

Study of Possible Brain Hormone Problems After Open Heart Surgery in Infants

Improving Well-being by Improving Memory for Treatment for Sleep and Circadian Dysfunction

Riluzole in Mild Alzheimer's Disease

A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

Prostate Cancer Survivors and Exercise and Behavioral Counseling

Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease

Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder

Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced Cardiotoxicity

Cognitive Screening Made Easy for PCPs - R33 Phase

Life-Stress Interview for Women With Chronic Urogenital Pain Conditions

Efficacy of VR101 as a Personal Lubricant